| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 10/28/2004 | WO2004078732B1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 10/28/2004 | WO2004078103A3 G-lactam derivatives as prostaglandin agonists |
| 10/28/2004 | WO2004075823A8 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 10/28/2004 | WO2004074502A3 A process of preparing imatinib |
| 10/28/2004 | WO2004058721A3 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 10/28/2004 | WO2004037789A3 Methylene urea derivatives as raf-kinase inhibitors |
| 10/28/2004 | WO2004013633A3 Method for isolating atp binding proteins by means of immobolized protein inhibitors |
| 10/28/2004 | US20040215021 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 10/28/2004 | US20040215019 Substituted isoindoles and the e use thereof |
| 10/28/2004 | US20040215014 Auroyl cyclic amines for controlling behavior or appetite |
| 10/28/2004 | US20040214999 Novel compounds for chemiluminescense procedures |
| 10/28/2004 | US20040214928 For therapy of proliferative disorders and neurological disorders |
| 10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
| 10/28/2004 | US20040214868 Treatment or prevention of type 2 diabetes; chemical synthesis; 2-[ benzoyl]aminopyridine-5-carboxylate derivatives |
| 10/28/2004 | US20040214857 Substituted benzimidazoles and imidazo-[4,5]-pyridines |
| 10/28/2004 | US20040214845 Barbiturates as integrin antagonists and their use for treating inflammatory diseases |
| 10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
| 10/28/2004 | US20040214841 Quinazoline derivatives for treatment of tumours |
| 10/28/2004 | US20040214832 Piperazine derivative renin inhibitors |
| 10/28/2004 | US20040214821 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
| 10/28/2004 | US20040214820 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them |
| 10/28/2004 | US20040214818 Alzheimer's disease; Parkinson's disease; Huntington's disease; cognition activators; learning enhancement; central nervous system disorders |
| 10/28/2004 | US20040214817 Diaminotriazoles useful as inhibitors of protein kinases |
| 10/28/2004 | US20040214816 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug |
| 10/28/2004 | US20040214107 optical and electro-optical apparatus comprising recording layer consists of organic pigments and stabilizer agents, and reflection layers formed on light transmitting substrates; sensitivity for red light |
| 10/28/2004 | US20040213947 Optical information-recording medium and dye |
| 10/28/2004 | CA2522522A1 Quinazoline compounds |
| 10/28/2004 | CA2522225A1 Carboxamide derivatives as anti-diabetic agents |
| 10/28/2004 | CA2522084A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 10/28/2004 | CA2521915A1 Alpha substituted carboxylic acid as ppar modulators |
| 10/28/2004 | CA2521841A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| 10/28/2004 | CA2521808A1 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 10/28/2004 | CA2521619A1 Aminoquinoline compounds |
| 10/28/2004 | CA2521135A1 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
| 10/28/2004 | CA2520804A1 Biaryl substituted pyrazoles as sodium channel blockers |
| 10/28/2004 | CA2520323A1 Tie-2 modulators and methods of use |
| 10/28/2004 | CA2520259A1 Cxcr4 chemokine receptor binding compounds |
| 10/28/2004 | CA2520255A1 Tie-2 modulators and methods of use |
| 10/27/2004 | EP1471065A1 Novel 1,2,4-triazole compound |
| 10/27/2004 | EP1471057A1 Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2 |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 10/27/2004 | EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
| 10/27/2004 | EP1470122A1 Rho-kinase inhibitors |
| 10/27/2004 | EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 10/27/2004 | EP1470120A1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives |
| 10/27/2004 | EP1470119A1 Benzothiophene compounds having antiinfective activity |
| 10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
| 10/27/2004 | EP1470108A1 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |
| 10/27/2004 | EP1469851A1 Melanocortin receptor agonists |
| 10/27/2004 | EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators |
| 10/27/2004 | EP1469839A2 Transmucosal delivery of proton pump inhibitors |
| 10/27/2004 | EP1469810A2 Compositions and methods for prevention and treatment of amyloid-beta peptide-related disorders |
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1315728B1 Process for the preparation of vitronectin receptor antagonists |
| 10/27/2004 | EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 10/27/2004 | EP1150952B1 Indole derivatives and their use as mcp-1 receptor antagonists |
| 10/27/2004 | EP0957100B1 Diamine derivatives and pharmaceutical containing the same |
| 10/27/2004 | EP0858996B1 Nerve cell protective agents |
| 10/27/2004 | CN1541334A Cardiovascular safety assay |
| 10/27/2004 | CN1541215A HIV inhibiting pyrimidines derivatives |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541206A Substituted dihydro 3-hylo-1H-pyrazoloe-5-carboxylates their prepn. and use |
| 10/27/2004 | CN1541205A Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring |
| 10/27/2004 | CN1541203A 4-(phenyl-(piperidin-4-YL)-amino)-benzamide derivatives and their use for treatment of pain, anxiety or gastrointestinal disorders |
| 10/27/2004 | CN1541098A Combination therapy for treatment of cancer |
| 10/27/2004 | CN1541086A Dyeing compson. for kerationous fibres comprising particular dicationic diazo dye |
| 10/27/2004 | CN1541063A Method for controlling particular insects by applying anthranilamide compounds |
| 10/27/2004 | CN1539825A Compounds useful to treat retroviral infections |
| 10/27/2004 | CN1172932C Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl-protein transferase |
| 10/27/2004 | CN1172931C Herbicidally active pyridine sulfonyl urea derivatives |
| 10/27/2004 | CN1172930C PDE IV inhibiting pyridine derivatives |
| 10/27/2004 | CN1172929C Substituted indoles for modulating NFKB activity |
| 10/27/2004 | CN1172917C Steroid receptor modulator compounds and methods |
| 10/27/2004 | CN1172911C Phtalimido arylpiperazines as alpha IA receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection |
| 10/26/2004 | US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects |
| 10/26/2004 | US6809107 Neurodegenerative diseases |
| 10/26/2004 | US6809106 Antiproliferation agents; such as 4-(2-methoxyphenoxy)-anilino-3-chloro-6,7-dimethoxyquinoline |
| 10/26/2004 | US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809098 Compounds |
| 10/26/2004 | US6809097 Antiangiogenic and/or vascular permeability |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6808939 Ligand for use as tool in diagnostic analysis |
| 10/26/2004 | CA2132514C Antiproliferative quinazolines |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089942A2 Benzimidazolidinone derivatives as muscarinic agents |
| 10/21/2004 | WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 10/21/2004 | WO2004089937A1 7-membered heterocyclic derivative |
| 10/21/2004 | WO2004089935A1 Novel crystalline forms of s-omeprazole magnesium |
| 10/21/2004 | WO2004089934A1 Processes for the preparation of n-((((pyridinyloxy) -phenylamino) quinazolinyl)- allyl) acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates |
| 10/21/2004 | WO2004089933A1 Novel crystal of fluorobenzamide derivative |
| 10/21/2004 | WO2004089932A1 Substituted pyrazole compounds |
| 10/21/2004 | WO2004089931A1 Substituted pyrazoles |